Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent. (Q42236944)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335707%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335707%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335707%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Ellis Patrick

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335707%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Golo Ahlenstiel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335707%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Vijay Suppiah

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335707%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Jean Yang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335707%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

K S O'Connor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335707%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

G Parnell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335707%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

D van der Poorten

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335707%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

S A Read

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335707%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

M W Douglas

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335707%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

G J Stewart

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335707%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

C Liddle

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335707%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

J George

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335707%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

D R Booth

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335707%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

16 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335707%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335707%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335707%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335707%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

88-94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24335707%20AND%20SRC:MED&resulttype=core&format=json

Course and outcome of hepatitis C

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

IL-28, IL-29 and their class II cytokine receptor IL-28R

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Interferon signaling and treatment outcome in chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Distinct and overlapping genomic profiles and antiviral effects of Interferon-λ and -α on HCV-infected and noninfected hepatoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Receptor density is key to the alpha2/beta interferon differential activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Metallothioneins in human tumors and potential roles in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Structure, organization, and regulation of human metallothionein IF gene: differential and cell-type-specific expression in response to heavy metals and glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Cell specificity and an effect of ras on human metallothionein gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Molecular functions of metallothionein and its role in hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Metallothioneins and zinc in cancer diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Metallothioneins negatively regulate IL-27-induced type 1 regulatory T-cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Metallothionein MT1M is a tumor suppressor of human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Hepatitis C virus NS5A-regulated gene expression and signaling revealed via microarray and comparative promoter analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Relation of IL28B gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

IFNalpha/beta promotes cell survival by activating NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Interferon-alpha-induced changes in metallothionein expression in liver biopsies from patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Early viral and peripheral blood mononuclear cell responses to pegylated interferon and ribavirin treatment: the first 24 h

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Diabetes and metallothionein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Metallothioneins: potential therapeutic aids for wound healing in the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Cell death in the injured brain: roles of metallothioneins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Metallothioneins in brain--the role in physiology and pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

A diverse range of gene products are effectors of the type I interferon antiviral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Ultrafast and memory-efficient alignment of short DNA sequences to the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Differential expression analysis for sequence count data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

α-Interferon-induced transcription of HLA and metallothionein genes containing homologous upstream sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2013.66

Preliminary study of combination therapy with interferon-alpha and zinc in chronic hepatitis C patients with genotype 1b

21 January 2018

1 reference

12 December 2020

National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C 2002 (June 10-12, 2002)

1 reference

12 December 2020

Metallothionein expression in animals: a physiological perspective on function

1 reference

12 December 2020

Cell-type specific gene expression signature in liver underlies response to interferon therapy in chronic hepatitis C infection

1 reference

12 December 2020

Hepatic metallothionein in patients with chronic hepatitis C: relationship with severity of liver disease and response to treatment

1 reference

12 December 2020

Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation

1 reference

12 December 2020

Hepatic cell-type specific gene expression better predicts HCV treatment outcome than IL28B genotype

1 reference

12 December 2020